To overcome this limitation, we previously reported that the combination of leptin administered peripherally with a protein tyrosine phosphatase 1B (PTP1B) inhibitor―an enhancer of leptin receptor signaling―improved glucose metabolism in a mouse model of IDDM in the absence of insulin [20]. Here, PTPN1 is linked to type 1 diabetes mellitus.